Galecto to Participate in Leerink Partners 2026 Global Healthcare Conference
BOSTON, March 02, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a biotechnology company working to redefine care for people with hematologic disorders, today announced that company management will participate in a fireside chat at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9, 2026 at 10:40 a.m. ET.
A live webcast of the Company’s presentation will be available under the “News & Events” tab in the Investor Calendar section of the Company’s website. An archived replay will be accessible for 30 days following the event.
About Galecto, Inc.
Galecto, Inc. is a clinical-stage biotechnology company advancing a pipeline of antibody therapeutics to transform treatment of a broad spectrum of hematological cancers. Galecto’s pipeline includes a highly differentiated mutant calreticulin (mut-CALR)-driven myeloproliferative neoplasm portfolio targeting essential thrombocythemia and myelofibrosis. Galecto’s pipeline also includes GB3226, a first-in-class preclinical dual inhibitor of ENL-YEATS and FLT3 for the treatment of multiple genetic subsets of acute myeloid leukemia.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
TRAVELERS COMPANIES INC <TRV.N> : HSBC CUTS TARGET PRICE TO $376 FROM $383
TRAVELERS COMPANIES INC : HSBC CUTS TARGET PRICE TO $376 FROM $383
Gold prices dip Rs 1,500/10 grams; silver down Rs 1,600/kg ahead of Fed minutes. Key levels to track
NASDAQ TRADE HALT CONTINUES <UCFIW.O> REASON NOT AVAILABLE AT 07:50 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 07:50 PM
$36M Pours Into Stellar RWAs As XLM Leads The Pack
Crypto prices
More
